About Index Trending news
Lists
Pricing
Ovid Therapeutics

Ovid Therapeutics

Ovid Therapeutics

Our mission is to provide innovative medicines to children and adults with neurological disorders.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

Latest funding Show all
IPO
$75,000,000
Venture capital (Series C)
$25,860,000
Employees

Unknown size

Locations
HQ
$75,000,000 IPO
Xconomy

With $75M Haul, Ovid Continues Flurry of Biotech IPOs

Health Science
$75,000,000 Venture capital (Series B)
Xconomy

Ex-Teva CEO's Brain Disease Startup, Ovid, Bags $75M From Crossovers

Health Funding